|
|
|
|
Delivering clinical trials in patients’ own communities and addressing patient diversity is a heavy task for sites and sponsors but a critical one that’s needed to make a difference for all patients and improve clinical trial outcomes. Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach, while improving recruitment and retention.
|
|
|
|
|
Decentralized clinical trial (DCT) elements can minimize or eliminate some of the problems that arise in traditional trials. However, a holistic approach is necessary to shape trials around DCT elements efficiently and compassionately. Learn how to select and implement DCT elements to drive your clinical trial forward and improve ROI in 2025.
|
|
|
|
|
The FDA's four-part patient-focused drug development (PFDD) guidance series provides a valuable roadmap for organizations working toward incorporating more patient-centric frameworks in their trial design. Discover key takeaways from the series, as well as insights into how achieve patient-centricity in trials with Home healthcare solutions.
|
|
|
|
|
Many factors influence oncology trial participation, often creating complex and costly hurdles for sponsors to navigate and participation barriers for patients. Explore how the right technology and support can help overcome these barriers to participation — creating value that benefits both sponsors and patients.
|
|
|
|
|
|
|
MRN will be attending and presenting at SCOPE Florida this February. As Market Leaders in community-centric Decentralized Clinical Trials (DCTs), this is your opportunity to meet in-person with the MRN Team and learn how we can increase enrollment and engagement and accelerate your trial timelines by bringing your trials to more patients in more communities. Schedule a meeting time here and visit us at Booth #1317.
|
|
|
